Use of dual-point fluorodeoxyglucose imaging to enhance sensitivity and specificity
O Schillaci - Seminars in nuclear medicine, 2012 - Elsevier
Positron emission tomography (PET) and positron emission tomography/computed
tomography imaging with fluorodeoxyglucose (FDG) are widely used as a powerful …
tomography imaging with fluorodeoxyglucose (FDG) are widely used as a powerful …
Clinical role of FDG PET in evaluation of cancer patients
L Kostakoglu, H Agress Jr, SJ Goldsmith - Radiographics, 2003 - pubs.rsna.org
Positron emission tomography (PET) is a diagnostic imaging technique that allows
identification of biochemical and physiologic alterations in tumors. Use of PET performed …
identification of biochemical and physiologic alterations in tumors. Use of PET performed …
PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients
K Endo, N Oriuchi, T Higuchi, Y Iida, H Hanaoka… - International journal of …, 2006 - Springer
Positron emission tomography (PET) using 2-18 F-fluoro-2-deoxy-D-glucose (FDG), a
radioactive derivative of glucose, is an advanced imaging tool, based on the increased …
radioactive derivative of glucose, is an advanced imaging tool, based on the increased …
Standardization and quantification in FDG-PET/CT imaging for staging and restaging of malignant disease
C Gámez-Cenzano, F Pino-Sorroche - PET clinics, 2014 - pet.theclinics.com
18F-fluorodeoxyglucose (FDG) is a glucose analog that accumulates preferentially in
malignant cells because of their higher glucose metabolism. PET/computed tomography …
malignant cells because of their higher glucose metabolism. PET/computed tomography …
False-positive uptake on 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography/computed tomography (PET/CT) in oncological imaging
AD Culverwell, AF Scarsbrook, FU Chowdhury - Clinical radiology, 2011 - Elsevier
With the increasing utilization of integrated positron-emission tomography/computed
tomography (PET/CT) using the glucose analogue 2-[18F]-fluoro-2-deoxy-d-glucose (FDG) …
tomography (PET/CT) using the glucose analogue 2-[18F]-fluoro-2-deoxy-d-glucose (FDG) …
[HTML][HTML] 18F-fluoro-2-deoxy-d-glucose (FDG) uptake. What are we looking at?
In the last decade, the possibility to map glucose consumption with 2-[18F] fluoro-2-deoxy-D-
glucose (FDG) imaging profoundly modified the daily activity of most nuclear medicine …
glucose (FDG) imaging profoundly modified the daily activity of most nuclear medicine …
Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology: Part IIIa: Therapy response monitoring in breast cancer, lymphoma and gliomas
B Van der Hiel, EKJ Pauwels, MPM Stokkel - Journal of cancer research …, 2001 - Springer
Positron emission tomography (PET) using 18 F-fluorodeoxyglucose (FDG) is considered to
be a very useful adjunct to anatomic imaging techniques and is now primarily used for …
be a very useful adjunct to anatomic imaging techniques and is now primarily used for …
Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants
A rapidly emerging clinical application of positron emission tomography (PET) is the
detection and staging of cancer with the glucose analogue tracer 2-[fluorine-18] fluoro-2 …
detection and staging of cancer with the glucose analogue tracer 2-[fluorine-18] fluoro-2 …
Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders
Fluorodeoxyglucose-PET (FDG-PET) has evolved into one of the major imaging modalities
commonly used in the management of a variety of malignancies [1, 2]. This application …
commonly used in the management of a variety of malignancies [1, 2]. This application …
Quantitative assessment of tumor metabolism using FDG-PET imaging
Positron emission tomography using the glucose analog fluorine-18 fluorodeoxyglucose
(FDG-PET) provides a unique means of non-invasive assessment of tumor metabolism …
(FDG-PET) provides a unique means of non-invasive assessment of tumor metabolism …